Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pandemic H5N1 Influenza”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01987011
What this trial is testing

Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers

Who this might be right for
Influenza
Green Cross Corporation 420
Not applicableWithdrawnNCT00640211
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B

Who this might be right for
Pandemic Influenza
Kirby Institute
Early research (Phase 1)Study completedNCT00709800
What this trial is testing

Pandemic Influenza Plasmid DNA Vaccines (Needle)

Who this might be right for
Influenza
Vical 56
Early research (Phase 1)Study completedNCT00664417
What this trial is testing

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi 375
Testing effectiveness (Phase 2)Study completedNCT01389466
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers

Who this might be right for
Influenza
Green Cross Corporation 346
Early research (Phase 1)Study completedNCT00812019
What this trial is testing

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Who this might be right for
Influenza
Seqirus 753
Early research (Phase 1)Study completedNCT00457509
What this trial is testing

Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic InfluenzaInfluenza A Virus InfectionOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 251
Testing effectiveness (Phase 2)Study completedNCT01323946
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 113
Early research (Phase 1)Study completedNCT00110279
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT00349141
What this trial is testing

Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 270
Early research (Phase 1)Study completedNCT02251288
What this trial is testing

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

Who this might be right for
Avian InfluenzaImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 62
Testing effectiveness (Phase 2)Study completedNCT00517517
What this trial is testing

Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 110
Testing effectiveness (Phase 2)Study completedNCT00545701
What this trial is testing

Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 100
Testing effectiveness (Phase 2)Study completedNCT00884182
What this trial is testing

Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children

Who this might be right for
InfluenzaOrthomyxoviridae InfectionsOrthomyxovirus Infections
Sanofi Pasteur, a Sanofi Company 350
Testing effectiveness (Phase 2)Study completedNCT00537524
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Who this might be right for
Prophylaxis of Avian Influenza
Novartis Vaccines 471
Testing effectiveness (Phase 2)Study completedNCT01776554
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 662
Early research (Phase 1)Study completedNCT01594320
What this trial is testing

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1

Who this might be right for
Influenza (Pandemic)
Novavax 333
Early research (Phase 1)Study completedNCT00356798
What this trial is testing

Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 120
Not applicableStudy completedNCT02743676
What this trial is testing

A Retrospective, Observational Registry of Participants With Avian Influenza Infection

Who this might be right for
Influenza
Hoffmann-La Roche 648
Large-scale testing (Phase 3)Study completedNCT01310413
What this trial is testing

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 842
Next Page